Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply
JAMA · 21.05.2024 · 331 (19) · 1676
DOI: 10.1001/jama.2024.2603 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, erschienen am 21.05.2024. Verfasst von Louis J Aronne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, New York, New York. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medical College, New York, New York.
Zitieren
APA
Aronne, L. J., & SURMOUNT-4 Investigators (2024). Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply. JAMA, 331(19), 1676. https://doi.org/10.1001/jama.2024.2603
Vancouver
Aronne LJ, SURMOUNT-4 Investigators. Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply. JAMA. 2024;331(19):1676. doi:10.1001/jama.2024.2603
BibTeX
@article{Aronne2024,
author = {Aronne, Louis J and SURMOUNT-4 Investigators, SURMOUNT-4 Investigators},
title = {Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply},
journal = {JAMA},
year = {2024},
volume = {331},
number = {19},
pages = {1676},
doi = {10.1001/jama.2024.2603}
}
EUVIMED